$Nyxoah SA(NYXH.US)$ Nyxoah Says DREAM US Pivotal Study Meets Primary Endpoints
Moomoo 24/7· 11 mins ago
Olivier Taelman, Nyxoah's Chief Executive Officer, said, "We are finalizing the fourth and final module submission in the PMA application and I look forward to launching Genio in the U.S, pending FDA approval."